The neuromuscular junction (NMJ) is the synapse formed between a lower motor neuron and a skeletal muscle fibre. The NMJ is known to be an early target in a number of conditions including motor neurone disease (MND), with most research into these conditions utilizing animal (rodent) models of disease. Our work to date has uncovered significant differences in the cellular and molecular anatomy of the human NMJ as compared with rodent NMJs, with major implications for translational work. A better understanding of these similarities and differences will aid in the translation of therapies developed in animal models to patients with MND.
Cellular and molecular anatomy of the human neuromuscular junction
About the project
Publication(s)
Recognising the potential of large animals for modelling neuromuscular junction physiology and disease
Journal of Anatomy 2022 Sep 02
DOI: 10.1111/joa.13749
A method to identify, dissect and stain equine neuromuscular junctions for morphological analysis
Journal of Anatomy 2022 Sep 22
DOI: 10.1111/joa.13747
Confocal endomicroscopy of neuromuscular junctions stained with physiologically inert protein fragments of tetanus toxin
Biomolecules. 11, 1499 2021 Oct 12
DOI: 10.3390/biom11101499
Terminal Schwann Cells at the Human Neuromuscular Junction
Brain Communications (open access) 2021 Apr 15
Comparative anatomy of the mammalian neuromuscular junction
Journal of Anatomy (open access) 2020 Jun 20
DOI: 10.1111/joa.13260
Neuromuscular junctions are stable in patients with cancer cachexia
Journal of Clinical Investigation
DOI: 10.1172/JCI128411
aNMJ-morph: a simple macro for rapid analysis of neuromuscular junction morphology
Royal Society Publishing (op[en access) 2020 Apr 15
DOI: 10.1098/rsos.200128
Cellular and Molecular Anatomy of the Human Neuromuscular Junction
Cell Reports (open access) 2017 Nov 28
NMJ-morph reveals principal components of synaptic morphology influencing structure-function relationships at the neuromuscular junction
Open Biology (open access) 2016 Dec 06
DOI: 10.1098/rsob.160240
Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy.
Human Molecular Genetics 2016 Jul 01
DOI: 10.1093/hmg/ddw141
Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy
JCI InSight (open access) 2016 Jul 21
Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis (ALS)
Neuropathology and Applied Neurobiology (2023) 2023 Aug 01
DOI: 10.1111/nan.12925
Neuromuscular impairment at different stages of human sarcopenia
Journal of Cachexia, Sarcopenia and Muscle (2024) 2024 Dec 15
DOI: 10.1002/jcsm.13624
Primary location
Principal Investigator
Other people involved
University of Edinburgh
- Thomas Gillingwater, Edinburgh Medical School
- Philippa Rust, Department of Orthopaedic Surgery NHS Lothian, St John's Hospital, Livingston
- Shahd Qutifan, PhD Student
- Abdullah Ramadan, PhD Student
University of New South Wales
- Izzy Jayasinghe, Molecular Medicine
Other people involved
University of Edinburgh
- Thomas Gillingwater, Edinburgh Medical School
- Philippa Rust, Department of Orthopaedic Surgery NHS Lothian, St John's Hospital, Livingston
- Shahd Qutifan, PhD Student
- Abdullah Ramadan, PhD Student
University of New South Wales
- Izzy Jayasinghe, Molecular Medicine
